Page 3 - Jubilant Life Sciences

Jubilant Life Sciences surges 12% on robust March quarter earnings

Reacting to its earnings, the stock advanced as much as 12.5% to Rs 762 on the BSE

Jubilant Life up over 5% as arm signs contracts in Radiopharma business

The stock was up 7% to Rs 683 on the BSE in intra-day trade

Jubilant Life Sciences hikes prices by up to 15% on select products

The hike applies to its Beta Picoline, 3-Cyanopyridine and Vitamin B3 formulations

Jubilant Life Q2 net profit up 14.51% at Rs 145 crore

International revenues were at Rs 984 crore, contributing 69% to the revenues for the quarter, the company said

Jubilant Life raises Rs 50 crore by issue of commercial papers

Jubilant stock closed at Rs 648.10 per scrip, up 0.79 per cent, on BSE

Jubilant Life gets USFDA nod for urinary incontinence drug

Jubilant Life Sciences said it has received 6 approvals from the USFDA during the year

Jubilant Life Sciences arm gets US FDA nod for coronary drug

Shares of the company were trading 6.82 per cent higher at Rs 656.55 on BSE

Jubilant Life Sciences rallies on USFDA nod for Ruby-Fill

The stock rallied 10% to Rs 676, also its record high on the BSE in intra-day trade.

Jubilant Life hits record high on ANDA approval for Felodipine ER tablets

The stock hit a record high of Rs 539, rallied 63% from Rs 330 on August 8, post Q1FY17 results.

Jubilant Life Sciences extends rally post Q1 results

The stock hit a record high of Rs 474, surging 44% in past seven trading sessions, as compared to 0.13% fall in Sensex.

Jubilant Life Sciences surges on strong Q1 results

The stock surged 11% to Rs 381 on the BSE during intra-day trade in otherwise weak market.

Jubilant Life Sciences gains on USFDA approval for epilepsy treatment injection

The stock has rallied 6% to Rs 374 on the BSE in an early morning trade

SES opposes Jubilant Life warrant issue

Option for deferred part payment of warrant money gives arbitrage opportunity for institutional buyers, says advisory firm

Jubilant Life gets USFDA nod for Sodium Chloride injection

The injection is the generic version of Hospira Inc's Sodium Chloride 0.9% injection in plastic container

Jubilant Life gains on pact with Cyclopharm for Technegas

Jubilant Draxlmage Inc and Cyclopharm Ltd have mutually terminated their previously announced term sheet for exclusive commercial rights of Technegas in the US market.